U.S. markets closed

Agile Therapeutics, Inc. (AGRX)

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Add to watchlist
0.6345-0.0437 (-6.44%)
At close: 04:00PM EDT
0.6400 +0.01 (+0.87%)
After hours: 07:05PM EDT
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Bullishpattern detected
Commodity Channel Index

Commodity Channel Index

Previous Close0.6782
Bid0.6345 x 800
Ask0.6400 x 1200
Day's Range0.6045 - 0.6599
52 Week Range0.4850 - 50.4000
Avg. Volume10,789,835
Market Cap19.992M
Beta (5Y Monthly)1.22
PE Ratio (TTM)N/A
EPS (TTM)-26.1610
Earnings DateAug 11, 2022
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est3.00
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Fair Value

Subscribe to Yahoo Finance Plus to view Fair Value for AGRX

View details
Research that delivers an independent perspective, consistent methodology and actionable insight
Related Research
  • Agile Therapeutics, Inc.
    Daily – Vickers Top Buyers & Sellers for 10/15/2021The Vickers Top Buyers & Sellers is a daily report that identifies the five companies the largest insider purchase transactions based on the dollar value of the transactions as well as the five companies the largest insider sales transactions based on the dollar value of the transactions.
    Fair Value
    Economic Moat
    10 months agoArgus Research
View more
  • GlobeNewswire

    Agile Therapeutics to Report Second Quarter 2022 Financial Results and Provide Business Update on Thursday, August 11, 2022

    Live Conference Call and Webcast at 4:30 p.m. ETPRINCETON, N.J., July 28, 2022 (GLOBE NEWSWIRE) -- Agile Therapeutics, Inc. (Nasdaq: AGRX), a women's healthcare company, today announced it will report second quarter 2022 financial results after the market close on Thursday, August 11, 2022. Following the release, the Company will host a live conference call and webcast at 4:30 p.m. ET to discuss the Company’s financial results and provide a business update. DateThursday, August 11, 2022Time4:30

  • Benzinga

    Woman-Health Focused Stock Agile Therapeutics Is 'Better Positioned,' Analyst Says While Upgrading Stock

    Maxim Group upgraded Agile Therapeutics Inc (NASDAQ: AGRX) to Buy from Hold with a price target of $1, saying it should be better positioned to begin to rebound. Agile recently closed an equity offering, raising around $24 million in gross proceeds, and brought in around $12.8 million from its ATM facility. The cash runway should be sufficient into 1Q23. In addition, management is enacting austerity measures and refining its commercial efforts, Maxim notes. Related: HC Wainwright Sees Agile Ther

  • Insider Monkey

    10 Best Penny Stocks to Buy in July

    In this article, we discuss the 10 best penny stocks to buy in July. If you want to see only the absolute top penny stocks to buy this month, check out 5 Best Penny Stocks to Buy in July. Penny stocks are priced under $5 and often represent high-risk public companies that do offer exponential […]